Clinical ResearchA Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials
Under an Elsevier user license
open archive
Key Words
drug-eluting stent(s)
SYNTAX score
Abbreviations and Acronyms
CABG
coronary artery bypass graft
CAD
coronary artery disease
MACE
major adverse cardiac event(s)
MI
myocardial infarction
PCI
percutaneous coronary intervention
ST
stent thrombosis
STEMI
ST-segment elevation myocardial infarction
SXscore
Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery score
TVR
target vessel revascularization
Cited by (0)
Dr. Garg has received honorarium from Medtronic. Dr. Valgimigli reports research grants for lecturers and advisory boards: Iroko, Eli Lilly, Medtronic, and honoraria for lecturers and/or advisory boards: Cordis, Medtronic, Abbott, Eisai, Merck, AstraZeneca, MedCo, and Terumo. Dr. Dawkins is an employee of Boston Scientific. Dr. Windecker received research grants Abbott, Biosensors, Biotronik, Cordis, Boston Scientific, and Medtronic. All other authors have reported that they have no relationships to disclose. John Hirshfeld, Jr., MD, served as Guest Editor for this paper.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.